期刊文献+

RP-HPLC法测定人血浆中拉莫三嗪及药动学 被引量:10

RP-HPLC determination of lamotrigine in human plasma and its pharmacokinetic studies
下载PDF
导出
摘要 目的建立RP-HPLC法测定人血浆中的拉莫三嗪,并将此方法应用于拉莫三嗪片在健康受试者体内的药动学研究。方法血浆样品经乙酸乙酯提取后,采用Kromasil C18柱分离,流动相为乙腈-20 mmol.L-1 KH2PO4(体积比为25∶75),流速为1.0 mL.min-1,检测波长为306 nm。测定了11名健康受试者口服拉莫三嗪片50 mg后不同时刻血浆中拉莫三嗪的浓度,采用DAS 2.0软件以非房室模型计算药动学参数。结果拉莫三嗪的线性范围为10.0~2 000.0μg.L-1;日内和日间精密度均小于8.0%,准确度(relative error,RE)在±2.6%以内,提取回收率大于59.1%。拉莫三嗪的主要药动学参数:t1/2为(39.1±8.2)h,tmax为(3.3±1.8)h,ρmax为(469.6±152.4)μg.L-1,AUC0-t为(22 424.6±6 952.6)μg.h.L-1,AUC0-∞为(25 573.2±7 196.4)μg.h.L-1。结论该方法适用于拉莫三嗪人体药动学研究。 Objective To develop a rapid and sensitive method for the determination of lamotrigine in human plasma by RP-HPLC for pharmacokinetic study.Methods Lamotrigine and internal standard were extracted from plasma with ethyl acetate and separated on a Kromasil C18 column using a mobile phase of acetonitrile-20 mmol · L-1 monopotassium phosphate(V∶ V=25∶ 75)at a flow rate of 1.0 mL · min-1.Quantitation was performed by measurement of the UV absorbance at a wavelength of 306 nm.Eleven healthy volunteers were given a single oral dose of 50 mg lamotrigine tablets,and the pharmacokinetic parameters were calculated by DAS 2.0 software using standard noncompartmental method.Results The assay was linear over the concentration range of 10.0-2 000.0 μg · L-1 for lamotrigine.The intra-day and inter-day precision was less than 8.0% and accuracy was within ±2.6%.The extraction recovery was more than 59.1%.The main pharmacokinetic parameters of lamotrigine were as follows:t1/2(39.1±8.2)h,tmax(3.3±1.8)h,ρmax(469.6±152.4)μg · L-1,AUC0-t(22 424.6±6 952.6)μg · h · L-1,AUC0-∞(25 573.2±7 196.4)μg · h · L-1.Conclusions The method is simple,rapid,sensitive and can be applied to human pharmacokinetic studies of lamotrigine.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2011年第7期545-548,共4页 Journal of Shenyang Pharmaceutical University
关键词 拉莫三嗪 高级液相色谱法 血浆药物浓度 lamotrigine HPLC plasma concentration
  • 相关文献

参考文献9

二级参考文献70

共引文献82

同被引文献77

  • 1宋志彬,廖卫平,易咏红,郑宣,扬春霞,赵绮华,蒲蜀湘.拉莫三嗪在有效血药浓度时对脑电波的影响[J].广州医学院学报,2003,31(4):16-18. 被引量:14
  • 2廖卫平,宋志彬,杨少青,蒲蜀湘,易咏红,赵绮华.拉莫三嗪治疗癫癎的有效性与剂量、血药浓度及合并用药关系的研究[J].中国神经精神疾病杂志,2005,31(6):438-441. 被引量:28
  • 3何大可,王丽,王寅初.反相高效液相色谱法同时测定拉莫三嗪和卡马西平血药浓度[J].药物分析杂志,2006,26(2):212-214. 被引量:16
  • 4Anderson GD, Gidal BE, Messenheimer JA, et al. Time course of lamotrigine de induction: impact of step wise with- drawal of carbamazepine or phenytoin [J]. Epilepsy Res, 2002, 49 (3): 211-217. 被引量:1
  • 5Zhang S, Wang I., Lu W. Population pharmacokinetics of lam- otrigine in Chinese children with epilepsy [J]. Zhongguo Dang Dai Er Ke Za Zhi, 2008, 10 (2): 105-109. 被引量:1
  • 6Otoul C, De Smedt H, Stockis A. Lack of pharmacokinetic in- teraction o levetiracetam on carbamazepine, valproic acid, topiranmte, and lamotrigine in children with epilepsy [J]. Epi- lepsia, 2007, 48 (11): 2111-2115. 被引量:1
  • 7Rivas N, Buelga DS, Elger CE, et al. Population pharmacoki- netics of lamotrigine with data from therapeutic drug monito- ring in German and Spanish patients with epilepsy [J] Ther DrugMonit, 2008, 30 (4): 483 489. 被引量:1
  • 8Punyawudho B, Ramsay RE, Macias FM, et al. Population pharmacokinetics of lamotrigine in elderly patients [J]. J Clin Pharmacol, 2008, 48 (4): 455 463. 被引量:1
  • 9Milovanovic JR, Jankovic SM. Population pharmacokinetics of lamotrigine in patients with epilepsy [J]. Int J Clin Pharmacol Ther, 2009, 47 (12): 752-760. 被引量:1
  • 10Bockbrader HN, Burger P, Knapp L. Pregabalin effect on steady state pharmaeokinetics of earbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiaga- bine [J]. Epilepsia, 2011, 52 (2): 405-409. 被引量:1

引证文献10

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部